There were a total of three of these pills. One pill required a full cup of water, and together with the small pills, another cup had to be swallowed.
So, Jiang Fuyue ended up downing four cups of water in total.
She finally managed to swallow them, and then the nausea started again.
Xie Dingyuan patiently, over and over again, gently stroked her back with his palm, from top to bottom.
“Feeling any better?”
Jiang Fuyue’s eyes were rimmed red from holding it in. Hearing this, she shook her head.
It took a full five minutes before she barely recovered.
“Which company made these pills? They’re way too inhumane. Such a big pill, how is anyone supposed to swallow that?”
Xie Dingyuan coughed lightly. “…Hanqing.”
“?”
“They were researched and manufactured by Hanqing Biotech, then exported to F Continent.”
Jiang Fuyue: “……” Complaining straight to the actual owner, was that okay?
“When you become Hanqing’s boss’s wife, with a single order, the product department will be on standby. You can change it to however small you want.”
When the man said this, his expression was serious, without the slightest hint of joking.
Jiang Fuyue: “……” That really isn’t necessary.
“Do you want more water?”
Jiang Fuyue: “Half a cup.”
Xie Dingyuan poured a cup, let her drink first, then downed the rest in one go.
“I want the experimental data related to the recombinant vaccine, as well as the clinical reports. Would it be convenient to provide them?” She hadn’t forgotten the purpose of this visit.
The man raised his brows. “What do you want those for?”
“To improve the protective ability of the existing vaccine. I saw in news reports that the current effectiveness rate is only fifty percent?”
Xie Dingyuan shook his head. “Actually, it’s even lower. From the clinical trial results, so far it’s only forty-three percent.”
Not even fifty.
Jiang Fuyue: “I’ve calculated using models. To establish an immune barrier, the vaccination rate in the North F Continent region needs to reach at least seventy percent. But that number assumes the vaccine’s effectiveness can be above fifty percent.”
“Then under the current situation, the required vaccination rate might be even higher.”
Xie Dingyuan: “But fundamentally, it’s still that the recombinant vaccine’s effectiveness is too low. I tried researching adenovirus vector vaccines, but the experimental results were unsatisfactory.”
Jiang Fuyue: “How so?”
“High safety, but insufficient effectiveness. It’s very hard to overcome ‘pre-existing immunity.’”
Jiang Fuyue pondered for a moment. “Then have you considered a live attenuated influenza virus vector vaccine?”
Xie Dingyuan paused slightly. “You mean using an already approved live attenuated influenza virus vaccine as the vector, carrying the Schankwo virus M protein, jointly stimulating the human body to produce antibodies against both viruses?”
“Yes, especially when Schankwo infections overlap with peak influenza seasons, the clinical significance would be huge. It’s equivalent to one vaccine preventing two diseases, fewer vaccinations, and relatively simpler administration…”
This discussion lasted two full hours in the blink of an eye.
Xie Dingyuan organized the relevant materials and clinical reports and handed them to Jiang Fuyue.
“…That’s basically everything.”
“Okay.” Jiang Fuyue nodded and put the materials into her bag.
Xie Dingyuan: “What I’m currently researching the most are inactivated vaccines and protein recombinant vaccines. The adenovirus vector vaccine is being studied by Bai Chuanhao’s team, they came along this time too, so progress shouldn’t be slow.”
He was reminding her.
If she truly decided to shift the next research focus to live attenuated vaccines, Jiang Fuyue would have to hurry.
As of now, on a global scale, no team had successfully developed this kind of vaccine.
There were barely any related papers, either.
Because proportionate to its significant advantages is its research difficulty.
Common live attenuated vaccines currently on the market include: Japanese encephalitis live attenuated vaccine, hepatitis A live attenuated vaccine, measles live attenuated vaccine, and so on.
Every single one of these went through a long development process before finally being released.
Xie Dingyuan: “You need to think it through, do you improve effectiveness on the basis of the existing protein recombinant vaccine, or start from scratch and research a live attenuated vaccine?”
The former isn’t easy, but at least there’s still hope in sight. The latter… can only be called a huge gamble.
Win, and the glory is limitless.
Lose, and you gain nothing.
After hearing this, Jiang Fuyue fell silent for a moment.
After a while, she spoke again: “I’ll think it through carefully.”
Xie Dingyuan nodded. “If you need anything, contact me on the intercom.”
Speaking of the intercom…
Jiang Fuyue: “I still don’t know your channel number.”
“29.1HZ.”
…
Jiang Fuyue picked up the materials and prepared to return next door. Xie Dingyuan walked her out.
“Think carefully about what I said and make a decision as soon as possible.”
“Okay.”
“Remember to take your medicine tomorrow. Forget it, just come over and take it here. I have everything prepared anyway.”
Jiang Fuyue: “……” No, I’m not coming.
“Then I’ll head back first.”
The man nodded, watching her retreating figure leave. Only after it disappeared from sight did he turn back.
Wherever they went, a wave of astonishment erupted—
“The professor didn’t lose his temper? He even personally walked her out?”
“Did we get the wrong script? Or did I walk onto the wrong set?”
“Am I the only one who saw what looked like a faint smile at the corner of the professor’s mouth?”
“To be honest, I saw it too.”
“So what exactly is going on now?”
Everyone looked at you, you looked at me, completely baffled.
And Xie Dingyuan had already passed through the crowd, bringing with him a gust of cool air. Suddenly, he stopped, turned around, and swept his gaze over the team members.
Everyone: “!” Level-one alert!
Want to show your support? Go donate at Paypal or Ko-fi to show your appreciation! :)
